EventsTuesday, November 17, 2015 04:30 PM - 05:30 PM
BIOGEN-Risk/Reward in Biotechnology: Can We Afford to Innovate?
An overview of Biogen’s unique business model, impressive drug development, and strategy for future innovation, as well as a discussion of pricing and financial returns for biotechnology companies and the expectations of patients, physicians, investors, and politicians. see the flyer here
Dr. George A. Scangos ’70
CEO of Biogen, a global biotechnology company which specializes in the discovery, development, and delivery of therapies for the treatment of neurodegenerative, hematologic, and autoimmune diseases.
Chairman-Elect of the Board of Directors of Pharmaceutical Research and Manufacturers of America (PhRMA).
Organized by Alumni Affairs & Development and hosted by the Entrepreneurship and Innovation Institute (EII) at the Samuel Curtis Johnson Graduate School of Management.